Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome

Journal Contribution ResearchOnline@JCU
Mahmood, Usman;Isbel, Nicole;Mollee, Peter;Mallett, Andrew;Govindarajulu, Sridevi;Francis, Ross
Andrew Mallett
Abstract

Haemolytic uraemic syndrome is a rare condition with an overall incidence ofone to two cases in a population of 100 000 and approximately 10% of thesecases are classified as atypical.1Atypical haemolytic uraemic syndrome (aHUS)is a thrombotic microangiopathy (TMA) characterized by microangiopathichaemolytic anaemia (MAHA), thrombocytopenia and acute kidney injury.aHUS can be genetic, acquired or idiopathic (negative genetic screening andno environmental triggers). We describe a case of aHUS triggered by monoclo-nal gammopathy of renal significance (MGRS) successfully treated with plas-mapheresis and a bortezomib-based chemotherapy regimen, resulting inmarked improvement in renal function and other markers of haemolysis. Thispatient has been in remission for more than 2 years currently.

Journal

Nephrology

Publication Name

Nephrology

Volume

22

ISBN/ISSN

1440-1797

Edition

N/A

Issue

Suppl. 1

Pages Count

3

Location

N/A

Publisher

Wiley-Blackwell Publishing Asia

Publisher Url

N/A

Publisher Location

N/A

Publish Date

N/A

Url

N/A

Date

N/A

EISSN

N/A

DOI

10.1111/nep.12934